CME Group Inc. logo

CME Group Inc. (CME)

Market Open
29 Jul, 14:42
NASDAQ (NGS) NASDAQ (NGS)
$
277. 80
+3.68
+1.34%
$
98.97B Market Cap
24.7 P/E Ratio
4.6% Div Yield
276,317 Volume
9.17 Eps
$ 274.12
Previous Close
Day Range
274.34 278
Year Range
193.25 290.79
Want to track CME and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 84 days
3 Stocks to Buy Before the May 7 Catalyst

3 Stocks to Buy Before the May 7 Catalyst

Tom Yeung here with your Sunday Digest.  In the 1990s, my father moved our family to a new overseas “Florida-style” housing development.

Investorplace | 3 months ago
CME Q1 Earnings Beat Estimates on Higher Trading Volume, Revenues Lag

CME Q1 Earnings Beat Estimates on Higher Trading Volume, Revenues Lag

CME Group's Q1 results reflect improved revenues and increased volatility that aided volumes.

Zacks | 3 months ago
CME Group Inc. Q1 2025 Earnings Call Transcript

CME Group Inc. Q1 2025 Earnings Call Transcript

CME Group Inc. Q1 2025 Earnings Conference Call April 23, 2025 8:30 AM ET Company Participants Adam Minick - Investor Relations Terry Duffy - Chairman & Chief Executive Officer Suzanne Sprague - Chief Operating Officer & Head, Risk and Clearing Sunil Cutinho - Chief Information Officer Lynne Fitzpatrick - Chief Financial Officer Derek Sammann - Global Head, Commodities Julie Winkler - Chief Commercial Officer Mike Dennis - Global Head, Fixed Income Conference Call Participants Kyle Voigt - KBW Dan Fannon - Jefferies Patrick Moley - Piper Sandler Ken Worthington - JP Morgan Ben Budish - Barclays Capital Bill Katz - TD Cowen Owen Lau - Oppenheimer Alex Kramm - UBS Craig Siegenthaler - Bank of America Brian Bedell - Deutsche Bank Alex Blostein - Goldman Sachs Ashish Sabadra - RBC Capital Markets Chris Allen - Citi Simon Clinch - Redburn Atlantic Operator Welcome to the CME Group First Quarter 2025 Earnings Call. At this time, I would like to inform all participants that your lines have been placed on a listen-only mode until the question-and-answer session of today's conference.

Seekingalpha | 3 months ago
CME (CME) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

CME (CME) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for CME (CME) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 3 months ago
CME Group (CME) Q1 Earnings Top Estimates

CME Group (CME) Q1 Earnings Top Estimates

CME Group (CME) came out with quarterly earnings of $2.80 per share, beating the Zacks Consensus Estimate of $2.79 per share. This compares to earnings of $2.50 per share a year ago.

Zacks | 3 months ago
Will Trading Volume Aid CME Group to Deliver Q1 Earnings Beat?

Will Trading Volume Aid CME Group to Deliver Q1 Earnings Beat?

CME's first-quarter performance is likely to have benefited from a diverse product portfolio, increased volatility and a strong market position.

Zacks | 3 months ago
Curious about CME (CME) Q1 Performance? Explore Wall Street Estimates for Key Metrics

Curious about CME (CME) Q1 Performance? Explore Wall Street Estimates for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for CME (CME), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.

Zacks | 3 months ago
If I Retired Today, These 3 Dividend Stocks Would Be My Paycheck

If I Retired Today, These 3 Dividend Stocks Would Be My Paycheck

The 60/40 portfolio used to be a rock-solid strategy. But persistent inflation and bond market volatility have turned the "safe" 40% into a real risk. I'm not a fan of bonds—and with good reason. I'd rather own high-quality businesses with dependable dividends and stronger long-term return potential. In this article, I highlight three stable, income-focused stocks I'd buy without hesitation to reduce portfolio risk and potentially outperform the 60/40 crowd.

Seekingalpha | 3 months ago
CME Group (CME) Earnings Expected to Grow: Should You Buy?

CME Group (CME) Earnings Expected to Grow: Should You Buy?

CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 3 months ago
3 Momentum Anomaly Stocks to Buy as Markets Rise on Tariff Pause

3 Momentum Anomaly Stocks to Buy as Markets Rise on Tariff Pause

JWN, EXE and CME are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.

Zacks | 3 months ago
CME Group (CME) Is Up 2.78% in One Week: What You Should Know

CME Group (CME) Is Up 2.78% in One Week: What You Should Know

Does CME Group (CME) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 3 months ago
Are Finance Stocks Lagging CME Group (CME) This Year?

Are Finance Stocks Lagging CME Group (CME) This Year?

Here is how CME Group (CME) and British Land Company PLC Sponsored ADR (BTLCY) have performed compared to their sector so far this year.

Zacks | 3 months ago
Loading...
Load More